500 patients in the INFERRCT trial

Thanks to the commitment of the Investigators and Study Personnel on sites, more than 500 patients have already been enrolled in the INFERRCT trial. Currently, recruitment is administered at 34 sites in Poland, and several more are waiting to be launched or awaiting for the enrollment of the first patient.
We sincerely thank all the Investigators for their active cooperation and support of patients at this crucial stage of the trial.